![Scott B. Waldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Scott B. Waldman is currently employed at Weil, Gotshal & Manges LLP since 2004.
Prior to this, he worked as the Chief Strategy Officer at Lonza Group AG from 2016 to 2020.
He also worked as the Senior Vice President-Corporate Development at Curia Global, Inc. from 2021 to 2023.
Anciens postes connus de Scott B. Waldman
| Sociétés | Poste | Fin |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Corporate Officer/Principal | 01/06/2023 |
| LONZA GROUP AG | Corporate Officer/Principal | 01/02/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Operates as a global contract research and manufacturing company that provides drug discovery, development & production services | Health Technology |
Lonza Group AG
 Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
